Jefferies Upgrades Oscar Health to Hold, Raises Price Target to $16

Benzinga Newsdesk www.benzinga.com Positive 88.5%

Neg 0% Neu 0% Pos 88.5%

Jefferies analyst David Windley upgrades Oscar Health (NYSE:OSCR) from Underperform to Hold and raises the price target from $10 to $16.